CytomX Announces Fourth Target Selection by Bristol-Myers Squibb Under Strategic Oncology Collaboration

World News: . []

SOUTH SAN FRANCISCO Calif Dec 05 2016 GLOBE NEWSWIRE -- CytomX Therapeutics Inc NasdaqCTMX a biopharmaceutical company developing investigational Probody therapeutics for the treatment of cancer today announced the selection of th e fourt...

More news and information about CytomX Therapeutics Inc.

Published By:

Globe Newswire: 13:00 GMT Monday 5th December 2016

Published: .

Search for other references to "cytomx" on SPi News


Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2017. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Ground Floor Offices, Little Keep Gate, Barrack Road, Dorchester, Dorset DT1 1AH
Registered in England and Wales number 0751938.
 
Privacy Policy | Terms and Conditions | Contact Us
 

Advertising on SPi News: Information For Advertisers